Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

352 Views

Z4. COVID-19 Treatment

Poster Session: COVID-19: Treatment

(P-2044) Analysis of Post COVID-19 Condition After Ensitrelvir Treatment in Asymptomatic or Mild-Symptoms Only Patients in the SCORPIO Phase2b/3 Study

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

TI

Takumi Imamura, M.Math

Employee
Shionogi
Osaka, Osaka, Japan

Co-Author(s)

HY

Hiroshi Yotsuyanagi, MD PhD

The University of Tokyo
Tokyo, Tokyo, Japan
NO

Norio Ohmagari, MD, MSc, PhD

Director
National Centre for Global Health and Medicine
Shinjuku, Tokyo, Japan
YD

Yohei Doi, MD, PhD

Fujita Health University
Aichi, Aichi, Japan
MY

Masaya Yamato, MD, PhD

Rinku General Medical Center
Izumisano, Osaka, Japan
HS

Hiroki Sakaguchi, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
HY

Hideki Yamanaka, n/a

Shionogi & Co., Ltd., Osaka, Japan
Osaka, Osaka, Japan
RI

Ryosuke Imaoka, n/a

Shionogi & Co., Ltd., Osaka, Japan
Osaka, Osaka, Japan
AF

Akimasa Fukushi, n/a

Shionogi & Co., Ltd., Osaka, Japan
Osaka, Osaka, Japan
GI

Genki Ichihashi, MA

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
YT

Yuko Tsuge, MSc

Shionogi
Osaka, Osaka, Japan
TU

Takeki Uehara, Ph.D.

SHIONOGI & CO., LTD.
Osaka-shi, Osaka, Japan
HM

Hiroshi Mukae, M.D., Ph.D.

Professor
Nagasaki University
Nagasaki, Nagasaki, Japan